MAUREEN ORONG: Open Payments
NPI 1457095309 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$948 in 38 payments from 18 companies in 2025. Trend: 2023 $849 · 2024 $1,213 · 2025 $948
Food & beverage: $948
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $201 |
| E.R. Squibb & Sons, L.L.C. | 2 | $116 |
| SCPHARMACEUTICALS INC. | 7 | $115 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Medtronic, Inc. | 3 | $74 |
| PFIZER INC. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| BridgeBio Pharma, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| ABIOMED | 1 | $30 |
Products named: JARDIANCE, CAMZYOS, FUROSCIX, VERQUVO, MICRA, ELIQUIS, LEQVIO, Attruby.
Industry payments across NY — which companies pay providers there.
